Page 6 - Solara Active Pharma Sciences News Today

Stock markets open on positive note: Sensex reclaims 58,100, Nifty above 17,300

As many as 170 stocks in the BSE 500 have lost over 25 per cent of their value.

While there is a mad rush for IPOs (initial public offerings), demergers have created massive wealth for investors without much hullabaloo

Ibuprofen API Market 2021: SWOT Analysis of Key Driving Factors for Growing CAGR Value | SI Group, Inc.,Perrigo Company,Alveda Pharmaceuticals,Reckitt Benc

Ibuprofen API Market 2021: SWOT Analysis of Key Driving Factors for Growing CAGR Value | SI Group, Inc.,Perrigo Company,Alveda Pharmaceuticals,Reckitt Benc

Glenmark manufacturing plant at Dahej, Gujarat; Image courtesy: Glenmark Synopsis The company’s performance has been robust — 16% CAGR in revenue and 17% CAGR in Ebitda over the last three years, and an Ebitda margin of over 30%. Besides, it has fared well in the critical parameter of quality compliance. It is now looking to expand its manufacturing capacity, product portfolio, and geographical presence, but can it continue its run? Active pharmaceutical ingredients (APIs) are the backbone ...

Explore Now Motilal Oswal has buy call on Solara Active Pharma Sciences with a target price of Rs 2000. The current market price of Solara Active Pharma Sciences is Rs 1710.4. Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 5927.33 Crore) operating in Pharmaceuticals sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 453.99 Crore, up 4.37 % from last quarter Total Inco...

Solara Active Pharma Sciences rose 3.10% to Rs 1,698.80 after Shivanand Shankar Mankekar bought 8.70 lakh equity shares or 2.42% stake at Rs 1,552.05 per share of the company via bulk deal on NSE on Monday (10 May 2021). Pronomz Ventures sold 8.70 lakh equity shares of Solara Active Pharma at Rs 1,552.05 per share via bulk deal on NSE on Monday. Professor Shivanand Shankar Mankekar is a high net-worth investor (HNI) and a former full-time professor at Mumbais Jamnalal Bajaj Institute of Managem...

Domestic indices saw profit taking after rising for four consecutive trading sessions on Tuesday. The Nifty 50 index ended near the 14,850 level. Metal, private banks corrected while media and PSU banks shares advanced. As per the provisional closing data, the barometer index, the S&P BSE Sensex, declined 340.6 points or 0.69% to 49,161.36. The Nifty 50 index fell 91.60 points or 0.61% at 14,850.10. The broader market outperformed the benchmark indices. The S&P BSE Mid-Cap index rose 0.6% whil...

SGX Nifty indicates positive note for Indian indices File Image The benchmark Indices are expected to open on a positive note as indicated by trends on SGX Nifty. US Indices closed with gains as Dow Jones hits a fresh new all-time high and Asian markets also opened stronger with Nikkei trading 2 percent higher. Key companies announcing their quarterly results today includes Adani Power, Coforge, Hero MotoCorp, Adani Transmission, P&G Health, Bluestar, Praj Industries and Tata Consumer. Immediat...